Sex Differences in Availability of β2*-Nicotinic Acetylcholine Receptors in Recently Abstinent Tobacco Smokers
Open Access
- 1 April 2012
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 69 (4) , 418-427
Abstract
Nicotine therapies (NTs) (eg, nicotine patch, gum, lozenge, and inhaler, as well as the nicotinic partial agonist therapy varenicline tartrate) are the most widely used treatments to help individuals quit smoking. Men respond better to NT than women,1 and women often have a more difficult time quitting smoking than men.2-6 Perkins7 demonstrated that men are better able than women to identify nicotine in a nasal spray and to discriminate nicotine from placebo, indicating that men are better able to detect the interoceptive cues of nicotine. Consistently, women experience greater craving relief than men from a denicotinized tobacco inhaler,8 highlighting the role sensory cues have in nicotine dependence for women. These results are consistent with findings showing that women are more reinforced than men by the nonnicotine-conditioned stimuli that are strongly associated with smoking, whereas men are more reinforced than women by the nicotine per se in cigarettes and in NT.9Keywords
This publication has 63 references indexed in Scilit:
- Individual Differences in Nicotine Dependence, Withdrawal Symptoms, and Sex Predict Transient fMRI-BOLD Responses to Smoking CuesNeuropsychopharmacology, 2007
- β2-subunit-containing nicotinic acetylcholine receptors are critical for dopamine-dependent locomotor activation following repeated nicotine administrationNeuropharmacology, 2004
- Self-administration of 5-iodo-A-85380, a β2-selective nicotinic receptor ligand, by operantly trained ratsNeuroReport, 2003
- Long‐lasting occupancy of central nicotinic acetylcholine receptors after smoking: a PET study in monkeysJournal of Neurochemistry, 2002
- Inhibition by pregnenolone sulfate of nicotinic acetylcholine response in adrenal chromaffin cellsEuropean Journal of Pharmacology, 2002
- Blockade of ionotropic receptor responses by progesterone in the ganglion cells of AplysiaNeuroscience Research, 2002
- Smoking cessation and the course of major depression: a follow-up studyThe Lancet, 2001
- Measurement of plasma metabolites of (S)-5-[123I]iodo-3- (2-azetidinylmethoxy)pyridine (5-IA-85380), a nicotinic acetylcholine receptor imaging agent, in nonhuman primatesNuclear Medicine and Biology, 2001
- 5-Iodo-A-85380, an α4β2 Subtype-Selective Ligand for Nicotinic Acetylcholine ReceptorsMolecular Pharmacology, 2000
- Sex differences in nicotine effects and self-administration: Review of human and animal evidenceNicotine & Tobacco Research, 1999